Week 10: Minor Cannabinoids: CBN, CBG, and Beyond

THC and CBD dominate most cannabis conversations, but they're just two of over 100 cannabinoids identified in the cannabis plant. The "minor" cannabinoids—compounds present in smaller quantities—are increasingly capturing the wellness community's attention.

As extraction technology advances and consumer interest grows, products featuring CBN, CBG, CBC, and other minor cannabinoids are becoming more available. Understanding these compounds helps you navigate the expanding cannabinoid marketplace.

What Are Minor Cannabinoids?

Minor cannabinoids are simply cannabinoids present in lower concentrations than THC and CBD in most cannabis plants. The term "minor" refers to quantity, not importance.

These compounds share the basic cannabinoid structure and interact with your endocannabinoid system, but each has its own unique characteristics and interaction patterns.

As the cannabis industry matures, breeding programs and extraction methods have made it possible to produce products featuring specific minor cannabinoids that were previously difficult to isolate.

CBN (Cannabinol)

CBN is one of the most well-known minor cannabinoids, often discussed in the context of sleep and nighttime routines.

How it forms. CBN is a degradation product of THC. As THC ages and is exposed to heat and oxygen, it gradually converts to CBN. This is why older cannabis tends to have higher CBN levels.

Characteristics. CBN is often discussed in the wellness community in relation to nighttime use. It's generally considered mildly psychoactive, though much less so than THC.

Products. CBN has become popular in products marketed for nighttime use, often combined with CBD or other sleep-supporting ingredients.

Availability. As demand has increased, CBN products have become more widely available, though they're typically pricier than standard CBD products due to the additional processing required.

CBG (Cannabigerol)

CBG is sometimes called the "mother cannabinoid" because it's the precursor from which other cannabinoids are synthesized in the plant.

The precursor role. In the cannabis plant, CBGA (the acidic form of CBG) is converted into THCA, CBDA, and CBCA by different enzymes. This means CBG is essentially the building block for other major cannabinoids.

Rarity in mature plants. Because CBG converts to other cannabinoids as the plant matures, most harvested cannabis contains very little CBG—typically less than 1%.

Growing interest. The wellness community has shown increasing interest in CBG, leading to the development of CBG-specific hemp strains and concentrated CBG products.

Characteristics. CBG is non-intoxicating and interacts with the endocannabinoid system in its own unique way. It has gained attention for its own distinctive properties.

CBC (Cannabichromene)

CBC is another non-intoxicating cannabinoid that's been gaining attention:

Abundance. CBC is actually one of the more abundant cannabinoids in the plant, though it's overshadowed by THC and CBD in most discussions.

Unique properties. CBC doesn't bind strongly to CB1 or CB2 receptors but may interact with other receptor systems in the body.

Limited products. Compared to CBN and CBG, fewer CBC-specific products are currently available, though this is changing as interest grows.

Other Minor Cannabinoids

Beyond CBN, CBG, and CBC, numerous other minor cannabinoids exist:

THCV (Tetrahydrocannabivarin). A THC analog that's been discussed for its potentially different effects profile. It's sometimes described as producing a shorter, clearer experience than THC.

CBDV (Cannabidivarin). A CBD analog that shares some similarities with CBD but has its own characteristics.

Delta-8 THC. An isomer of the more common Delta-9 THC that occurs naturally in small amounts. It's become controversial due to regulatory questions about synthetically converting CBD to Delta-8.

THCA and CBDA. The acidic precursors to THC and CBD found in raw cannabis. These convert to their more familiar forms when heated (decarboxylated).

CBL (Cannabicyclol). Formed from CBC degradation, another example of how cannabinoids change over time.

Each of these compounds has its own characteristics, though many remain less well understood than the major cannabinoids.

The Entourage Effect

The concept of the entourage effect is particularly relevant when discussing minor cannabinoids:

Working together. The entourage effect suggests that cannabis compounds may work synergistically, with the combined effect differing from what any single compound produces alone.

Full-spectrum products. This concept underlies the appeal of full-spectrum products, which retain the natural variety of cannabinoids and terpenes.

Minor cannabinoid contributions. Minor cannabinoids may play roles in the entourage effect, potentially influencing the overall experience of full-spectrum products even when present in small amounts.

Individual compounds. Conversely, isolated minor cannabinoids allow for exploring each compound's individual characteristics without interference from others.

What to Consider with Minor Cannabinoid Products

If you're interested in exploring minor cannabinoid products:

Quality standards. Apply the same quality standards as with CBD products—look for third-party testing, transparent sourcing, and clear labeling.

Limited information. Less is known about minor cannabinoids compared to THC and CBD. Approach with appropriate caution and realistic expectations.

Higher prices. Minor cannabinoid products are often more expensive due to the additional processing and lower yields involved in their production.

Individual variation. As with all cannabinoids, individual responses vary. What works for someone else may not work for you.

Consult healthcare providers. Especially if you take medications or have health conditions, discuss any new supplements with your healthcare provider.

The Expanding Cannabinoid Landscape

The minor cannabinoid market represents one of the fastest-evolving areas of the cannabis industry:

Continued discovery. New cannabinoids are still being identified, and understanding of existing ones continues to develop.

Breeding advances. Cannabis breeders are developing strains high in specific minor cannabinoids, making production more economically viable.

Product innovation. As interest grows, expect to see more products featuring specific cannabinoid profiles and combinations.

Regulatory attention. As the market expands, regulatory frameworks are likely to evolve. Stay informed about legal developments in your jurisdiction.

Key Takeaways

• Cannabis contains over 100 cannabinoids beyond THC and CBD
• CBN is associated with aged cannabis and often marketed for nighttime use
• CBG is the "mother cannabinoid" from which other cannabinoids form
• CBC is abundant but less commonly featured in products
• Minor cannabinoids may contribute to the entourage effect
• Apply the same quality standards to minor cannabinoid products as to CBD

---